Doing Business In Brazil

ima logo
/media/100734/br_bannertext.png
 

News 21

Oxford Pharmascience: On the road to profitability

January 24th this year was an important landmark for Oxford Pharmascience (LON:OXP), though it passed with little fanfare.

It marked the date of the company's official launch of its first licensed product in Brazil by its partner and a significant milestone along the road to profitability.

The early signs of this can be seen with the first two orders helping the group lift last year's revenues by over 230 per cent to £292,000, while a further two orders have been banked already this year.

The partner is Aché Laboratórios Farmacêuticos, or Aché for short, one of the largest pharmaceuticalcompanies in Brazil and which has launched a calcium and vitamin D soft chew using the company's OXP chew technology.

To read the full article, please click here

Source - http://www.proactiveinvestors.co.uk/

 

Partner Profiles